BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21269527)

  • 1. Effects of purchaser competition in the Dutch health system: is the glass half full or half empty?
    Schut FT; van de Ven WP
    Health Econ Policy Law; 2011 Jan; 6(1):109-23. PubMed ID: 21269527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a business case for quality in The Netherlands? A critical analysis of the recent reforms of the health care system.
    Custers T; Arah OA; Klazinga NS
    Health Policy; 2007 Jul; 82(2):226-39. PubMed ID: 17070956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed competition in The Netherlands: lessons from five years of health care reform.
    van de Ven W; Rutten F
    Aust Health Rev; 1995; 18(1):9-27. PubMed ID: 10141966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The politics of health-care reform in the Netherlands since 2006.
    Maarse H; Paulus A
    Health Econ Policy Law; 2011 Jan; 6(1):125-34. PubMed ID: 21269528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Dutch health care a model for the U.S. health system?
    Frieden J
    Bus Health; 1992 May; 10(6):34-5, 38, 40-2. PubMed ID: 10119118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationing and competition in the Dutch health-care system.
    Schut FT; Van de Ven WP
    Health Econ; 2005 Sep; 14(Suppl 1):S59-74. PubMed ID: 16161190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Market competition in health care markets in the Netherlands: some lessons for England?
    den Exter AP; Guy MJ
    Med Law Rev; 2014; 22(2):255-73. PubMed ID: 24841530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences and choices for care and health insurance.
    van den Berg B; Van Dommelen P; Stam P; Laske-Aldershof T; Buchmueller T; Schut FT
    Soc Sci Med; 2008 Jun; 66(12):2448-59. PubMed ID: 18400349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The purchaser-provider split in New Zealand: the story so far.
    Ashton T
    Aust Health Rev; 1995; 18(1):43-60. PubMed ID: 10141963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reforming health care in The Netherlands.
    te Maarssen AM; Janssen R
    Health Serv Manage; 1994 Jan; 90(1):19-21. PubMed ID: 10134206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experiment with regulated competition and individual mandates for universal health care: the new Dutch health insurance system.
    Rosenau PV; Lako CJ
    J Health Polit Policy Law; 2008 Dec; 33(6):1031-55. PubMed ID: 19038869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing risk selection incentives in health sector reforms.
    Puig-Junoy J
    Int J Health Plann Manage; 1999; 14(4):287-311. PubMed ID: 11184915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shepherding major health system reforms: a conversation with German health minister Ulla Schmidt. Interview by Tsung-Mei Cheng and Uwe Reinhardt.
    Schmidt U
    Health Aff (Millwood); 2008; 27(3):w204-13. PubMed ID: 18397935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.
    van Kleef RC; van de Ven WP; van Vliet RC
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):743-52. PubMed ID: 24219050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of order and complements: a new way to understand the Dutch and German health insurance reforms.
    Helderman JK; Stiller S
    J Health Polit Policy Law; 2014 Aug; 39(4):811-40. PubMed ID: 24842966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease management and health care reforms in Germany - does more competition lead to less solidarity?
    Stock SA; Redaelli M; Lauterbach KW
    Health Policy; 2007 Jan; 80(1):86-96. PubMed ID: 16600418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of injecting price competition into the hospital market: the case of preferred provider organizations.
    Dranove D; Satterthwaite M; Sindelar J
    Inquiry; 1986; 23(4):419-31. PubMed ID: 2947862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A living model of managed competition: a conversation with Dutch health minister Ab Klink. Interview by Alain Enthoven.
    Klink A
    Health Aff (Millwood); 2008; 27(3):w196-203. PubMed ID: 18397934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new Dutch reformation.
    Pentecost MJ
    J Am Coll Radiol; 2008 Apr; 5(4):544-5. PubMed ID: 18359439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.